| Fibrin-bound thrombin determines clot structure and blood thrombogenicity in normofibrinogenemia and dysfibrinogenemia | Haematologica | | | 2026 | 18 | 19 |
|
| Rare Bleeding Disorders and Bleeding Disorder of Unknown Cause : Current Understanding and Recent Developments | Haemophilia | | | 2026 | 6 | 59 |
|
| The fibrinogen αC region promotes arterial thrombosis in the context of hypofibrinogenemia | Blood | | | 2026 | 28 | 104 |
|
| Targeted long-read sequencing identifies a novel 1.3 kb FGG deletion associated with variable bleeding and thrombotic phenotypes in hypofibrinogenemia | Research and practice in thrombosis and haemostasis | | | 2026 | 3 | 3 |
|
| Successful Treatment of Heavy Menstrual Bleeding in a Woman With Mild Haemophilia A Using Efanesoctocog Alfa | Haemophilia | | | 2026 | 12 | 0 |
|
| Another step toward phenotypic characterization of hereditary dysfibrinogenemia ? | Research and practice in thrombosis and haemostasis | | | 2026 | 5 | 39 |
|
| An Unusual Association Between Acquired Hemophilia A and Type 2 Autoimmune Pancreatitis | Hämostaseologie | | | 2026 | 8 | 49 |
|
| Fibrinogen Dusart Escapes Clauss‐ CWA Screening in a Genotype‐Confirmed Dysfibrinogenemia Cohort | International journal of laboratory hematology | | | 2026 | 9 | 0 |
|
| Standardization of scanning electron microscopy analysis of fibrin fiber diameter measurement : communication from the ISTH SSC subcommittee on FXIII and fibrinogen | Journal of thrombosis and haemostasis | | | 2026 | 7 | 51 |
|
| A Novel Heterozygous Mutation in FGB (c.1231_1232 del GA) Causing Hypofibrinogenemia With Mild Bleeding in a Large Swiss family | Haemophilia | | | 2026 | 7 | 0 |
|
| The Hypofibrinolysis State Associated with the Dysfibrinogenemia Dusart is Mainly Related to the Altered Fibrin Clot Structure | Hämostaseologie | | | 2026 | 15 | 251 |
|
| Management of Young and Ageing Women with Afibrinogenemia and Hypofibrinogenemia | Hämostaseologie | | | 2025 | 41 | 326 |
|
| How I treat quantitative fibrinogen disorders | Blood | | | 2025 | 78 | 16 |
|
| The thrombotic paradox in congenital fibrinogen deficiencies: from pathophysiology to practice | Research and practice in thrombosis and haemostasis | | | 2025 | 31 | 48 |
|
| Women and hereditary bleeding disorders | Hämostaseologie | | | 2025 | 89 | 886 |
|
| Gynecologic and obstetric complications in women with congenital fibrinogen disorders: insights from the Prospective Rare Bleeding Disorders Database | Research and practice in thrombosis and haemostasis | | | 2025 | 39 | 166 |
|
| Enhancing hemostasis potency in hemophilia with a small interfering ribonucleic acid targeting protein S | Journal of thrombosis and haemostasis | | | 2025 | 35 | 0 |
|
| A novel FGG missense variant associated with fibrinogen storage disease in a large family from Quebec | Haemophilia | | | 2024 | 85 | 0 |
|
| Perinatal stroke and hypofibrinogenemia : Is the new missense fibrinogen variant γ p.Gly310Glu the cause of the procoagulant state ? | Thrombosis research | | | 2024 | 104 | 0 |
|
| Angiologie et hémostase : ce qui a changé en 2023 | Revue médicale suisse | | | 2024 | 117 | 32 |
|
| Diagnostic value of clot formation parameters determined by rotational thromboelastometry in 63 patients with congenital dysfibrinogenemia | Blood coagulation & fibrinolysis | | | 2024 | 106 | 299 |
|
| Congenital fibrinogen disorders: a retrospective clinical and genetic analysis of the Prospective Rare Bleeding Disorders Database | Blood advances | | | 2024 | 138 | 172 |
|
| Santé cardiovasculaire et médecine transgenre | Revue médicale suisse | | | 2024 | 22 | 3 |
|
| Management of anticoagulation and factor XIII replacement in a patient with severe factor XIII deficiency and recurrent venous thromboembolic disease: case report and review of literature | Research and practice in thrombosis and haemostasis | | | 2024 | 133 | 180 |
|
| Management of pregnancy and delivery in congenital fibrinogen disorders: communication from the ISTH SSC Subcommittee on Factor XIII and Fibrinogen | Journal of thrombosis and haemostasis | | | 2024 | 104 | 0 |
|
| Rare bleeding disorders: Advances in management | Haemophilia | | | 2024 | 71 | 584 |
|
| Clinical, laboratory, and molecular aspects of congenital fibrinogen disorders | Seminars in thrombosis and hemostasis | | | 2024 | 101 | 0 |
|
| How to investigate mild to moderate bleeding disorders and bleeding disorder of unknown cause | International journal of laboratory hematology | | | 2024 | 92 | 728 |
|
| Saignements utérins anormaux et anomalies de l’hémostase | Revue médicale suisse | | | 2024 | 39 | 35 |
|
| Highly thrombogenic phenotype and impaired wound healing in a patient with congenital dysfibrinogenemia : case report | Research and practice in thrombosis and haemostasis | | | 2024 | 130 | 122 |
|
| Challenges in the diagnosis and management of patients with rare coagulation disorders in Lebanon and consequences of a social and economic crisis | Haemophilia | | | 2024 | 59 | 0 |
|
| 2023 ACR/EULAR antiphospholipid syndrome classification criteria | Annals of the rheumatic diseases | | | 2023 | 193 | 2,476 |
|
| Physiological correction of hereditary mild hypofibrinogenemia during pregnancy | Haemophilia | | | 2023 | 225 | 679 |
|
| Addressing some challenges of congenital fibrinogen disorders in 2023 and beyond | Bleeding, thrombosis and vascular biology | | | 2023 | 78 | 351 |
|
| Angiologie et hémostase : ce qui a changé en 2022 | Revue médicale suisse | | | 2023 | 131 | 124 |
|
| Recommendations for the use of andexanet alfa in the management of bleeding in patients on oral factor Xa inhibitors in Switzerland: Guideline from the Working Party Hemostasis of the Swiss Society of Hematology | Swiss medical weekly | | | 2023 | 101 | 635 |
|
| Pharmacodynamics Monitoring of Emicizumab in Patients with Hemophilia A | Thrombosis and haemostasis | | | 2023 | 189 | 0 |
|
| 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria | Arthritis & rheumatology | | | 2023 | 119 | 0 |
|
| High incidence of intracranial haemorrhage in Egyptian children with congenital afibrinogenaemia | Haemophilia | | | 2023 | 75 | 0 |
|
| International council for standardisation in haematology recommendations on fibrinogen assays, thrombin clotting time and related tests in the investigation of bleeding disorders | International journal of laboratory hematology | | | 2023 | 98 | 232 |
|
| Coexpression of factor VIII and factor von Willebrand variants in a woman with heavy menstrual bleeding | Blood coagulation & fibrinolysis | | | 2023 | 87 | 0 |
|
| Management of rare inherited bleeding disorders: Proposals of the French Reference Centre on Haemophilia and Rare Coagulation Disorders | European journal of haematology | | | 2023 | 104 | 822 |
|
| Longitudinal profile of estrogen-related thrombotic biomarkers after cessation of combined hormonal contraceptives | Blood | | | 2023 | 126 | 339 |
|
| Obstetrical complications in hereditary fibrinogen disorders: the Fibrinogest Study | Journal of thrombosis and haemostasis | | | 2023 | 98 | 0 |
|
| Prothrombotic biomarkers during controlled ovarian stimulation for assisted reproductive technology | Fertility and sterility | | | 2023 | 149 | 0 |
|
| Effect of therapeutic anticoagulation on gas exchange in mechanically ventilated COVID-19 patients: A secondary analysis of the COVID-HEP trial | Thrombosis research | | | 2023 | 326 | 99 |
|
| Clinicians’ adherence to guidelines for the preoperative management of direct oral anticoagulants in a tertiary hospital: a retrospective study | BMC anesthesiology | | | 2023 | 105 | 251 |
|
| Fifty years of fibrinogen structure and function | Seminars in thrombosis and hemostasis | | | 2023 | 135 | 23 |
|
| Hemizygous FGG p.Ala108Gly in a hypofibrinogenemic patient with a heterozygous 14.8 Mb deletion encompassing the entire fibrinogen gene cluster | Haemophilia | | | 2022 | 251 | 2 |
|
| Differential impact of tamoxifen and aromatase inhibitors on thrombin generation: the prospective HEMOBREAST cohort | Blood advances | | | 2022 | 296 | 686 |
|
| Angiologie-hémostase - Année 2021 : morceaux choisis | Revue médicale suisse | | | 2022 | 108 | 147 |
|
| One Hundred Years of Congenital Fibrinogen Disorders | Seminars in thrombosis and hemostasis | | | 2022 | 334 | 0 |
|
| Place des anticoagulants oraux directs dans le traitement des thromboses veineuses de localisation inhabituelle | Revue médicale suisse | | | 2022 | 147 | 317 |
|
| Impact of fibrinogen infusion on thrombin generation and fibrin clot structure in patients with inherited afibrinogenemia | Thrombosis and haemostasis | | | 2022 | 185 | 2 |
|
| Therapeutic anticoagulation to prevent thrombosis, coagulopathy, and mortality in severe COVID-19: The Swiss COVID-HEP randomized clinical trial | Research and practice in thrombosis and haemostasis | | | 2022 | 259 | 327 |
|
| A homozygous duplication of the FGG exon 8-intron 8 junction causes congenital afibrinogenemia. Lessons learned from the study of a large consanguineous Turkish family | Haematologica | | | 2022 | 354 | 350 |
|
| Saignements d’origine indéterminée : approche diagnostique et thérapeutique | Revue médicale suisse | | | 2022 | 96 | 474 |
|
| How I treat dysfibrinogenemia | Blood | | | 2021 | 357 | 5,916 |
|
| Novel missense mutations affecting the structure of the conserved fibrinogen Bβ C-terminal domain cause congenital hypofibrinogenemia | Thrombosis Research | | | 2021 | 220 | 278 |
|
| Afibrinogenemia with two compound heterozygous mutations in FGA gene | Haemophilia | | | 2021 | 291 | 0 |
|
| Fibrin clot properties to assess the bleeding phenotype in unrelated patients with hypodysfibrinogenemia due to novel fibrinogen mutations | Thrombosis research | | | 2021 | 593 | 12 |
|
| Whole blood thromboelastometry by ROTEM and thrombin generation by genesia according to the genotype and clinical phenotype in congenital fibrinogen disorders | International Journal of Molecular Sciences | | | 2021 | 243 | 99 |
|
| Clinical phenotype, fibrinogen supplementation, and health-related quality of life in patients with afibrinogenemia | Blood | | | 2021 | 304 | 325 |
|
| Comparison of different activators of coagulation by turbidity analysis of hereditary dysfibrinogenemia and controls | Blood Coagulation and Fibrinolysis | | | 2021 | 239 | 0 |
|
| Perioperative management of a severe congenital hypofibrinogenemia with thrombotic phenotype | Thrombosis Research | | | 2020 | 373 | 65 |
|
| Identification and expression of a novel heterozygous frameshift mutation in FGA accounting for congenital hypofibrinogenemia in carriers of severe hemophilia A | Thrombosis Research | | | 2020 | 281 | 2 |
|
| Venous thromboembolism in COVID-19: systematic review of reported risks and current guidelines | Swiss Medical Weekly | | | 2020 | 550 | 264 |
|
| Risque thrombotique veineux induit par le SARS-CoV-2 : prévalence, recommandations et perspectives | Revue médicale suisse | | | 2020 | 353 | 261 |
|
| From Routine to Research Laboratory: Strategies for the Diagnosis of Congenital Fibrinogen Disorders | Hämostaseologie | | | 2020 | 284 | 3 |
|
| Fibrin(ogen) in human disease: both friend and foe | Haematologica | | | 2020 | 488 | 490 |
|
| A Unique Case of Acquired Hemophilia A Presenting with Transient Ischemic Attack | Acta Haematologica | | | 2020 | 348 | 409 |
|
| Contraception et maladie thromboembolique veineuse | Revue médicale suisse | | | 2020 | 287 | 348 |
|
| Suggestions for thromboprophylaxis and laboratory monitoring for in-hospital patients with COVID-19 | Swiss Medical Weekly | | | 2020 | 376 | 815 |
|
| Safety of variceal band ligation in patients with cirrhosis and portal vein thrombosis treated with anticoagulant therapy: A retrospective study | European Journal of Gastroenterology and Hepatology | | | 2020 | 424 | 652 |
|
| Recommendations on the use of anticoagulants for the treatment of patients with heparin-induced thrombocytopenia in Switzerland | Swiss Medical Weekly | | | 2020 | 625 | 436 |
|
| A novel nonsense mutation in FBG (c.1421G>A;p.Trp474Ter) in the beta chain of fibrinogen causing hypofibrinogenemia with bleeding phenotype | Biomedicines | | | 2020 | 290 | 176 |
|
| Molecular characterization of two hypofibrinogenemic patients associated with a novel FGG IVS6+23T>A substitution and a previously reported FGB IVS6-10_16delTTTG deletion | Haemophilia | | | 2020 | 351 | 0 |
|
| Heterogeneity of congenital afibrinogenemia, from epidemiology to clinical consequences and management | Blood Reviews | | | 2020 | 276 | 557 |
|
| Management of bleeding events and invasive procedures in patients with haemophilia A without inhibitors treated with emicizumab | Swiss medical weekly | | | 2020 | 207 | 150 |
|
| Hepatocellular type II fibrinogen inclusions in a patient with severe COVID-19 and hepatitis | Journal of Hepatology | | | 2020 | 419 | 142 |
|
| Congenital structural and functional fibrinogen disorders: a primer for internists | Polskie Archiwum Medycyny Wewnetrznej | | | 2019 | 555 | 485 |
|
| Fibrinogen concentrates in hereditary fibrinogen disorders: past, present and future | Haemophilia | | | 2019 | 320 | 0 |
|
| Obstetrical and postpartum complications in women with hereditary fibrinogen disorders: a systematic literature review | Haemophilia | | | 2019 | 439 | 1 |
|
| Impaired factor XIII activation in patients with congenital afibrinogenemia | Haematologica | | | 2019 | 368 | 152 |
|
| A unique factor XIII mutation in southeastern Iran with an unexpectedly high prevalence: khash factor XIII | Seminars in Thrombosis and Hemostasis | | | 2019 | 385 | 0 |
|
| The impact of haemophilia on the social status and the health-related quality of life in adult Lebanese persons with haemophilia | Haemophilia | | | 2019 | 384 | 0 |
|
| Thrombin generation and fibrin clot structure after vitamin D supplementation | Endocrine Connections | | | 2019 | 398 | 205 |
|
| Fundamentals for a Systematic Approach to Mild and Moderate Inherited Bleeding Disorders: An EHA Consensus Report | HemaSphere | | | 2019 | 283 | 603 |
|
| Hereditary fibrinogen disorders: toward a tailored management | | | | 2019 | 368 | 13 |
|
| Antithrombotiques dans le syndrome des anticorps antiphospholipides thrombotique | Revue médicale suisse | | | 2018 | 364 | 191 |
|
| Clinical Consequences and Molecular Bases of Low Fibrinogen Levels | International Journal of Molecular Sciences | | | 2018 | 603 | 329 |
|
| Heterozygous FGA p.Asp473Ter (fibrinogen Nieuwegein) presenting as antepartum cerebral thrombosis | Thrombosis Research | | | 2018 | 480 | 1 |
|
| Mutational epidemiology of congenital fibrinogen disorders | Thrombosis and Haemostasis | | | 2018 | 603 | 1,061 |
|
| Traitements antithrombotiques et anomalies constitutionnelles hémorragipares de l'hémostase | Revue médicale suisse | | | 2018 | 383 | 176 |
|
| Acide tranexamique dans la prise en charge de l'hémorragie du postpartum : connaissances actuelles | Revue médicale suisse | | | 2018 | 457 | 329 |
|
| A fibrin biofilm covers blood clots and protects from microbial invasion | Journal of Clinical Investigation | | | 2018 | 520 | 363 |
|
| Diagnosis and classification of congenital fibrinogen disorders: communication from the SSC of the ISTH | Journal of Thrombosis and Haemostasis | | | 2018 | 443 | 608 |
|
| Fibrinogen Mahdia: A congenitally abnormal fibrinogen characterized by defective fibrin polymerization | Haemophilia | | | 2017 | 449 | 1 |
|
| Genetics, diagnosis and clinical features of congenital hypodysfibrinogenemia: a systematic literature review and report of a novel mutation | Journal of thrombosis and haemostasis | | | 2017 | 629 | 851 |
|
| Thromboses veineuses splanchniques | Revue médicale suisse | | | 2017 | 452 | 320 |
|
| A novel fibrinogen mutation: FGA g. 3057 C > T (p. Arg104 > Cys) impairs fibrinogen secretion | BMC Hematology | | | 2017 | 464 | 305 |
|
| Protein modelling to understand FGB mutations leading to congenital hypofibrinogenaemia | Haemophilia | | | 2017 | 572 | 4 |
|
| Impact of pneumatic tube system transport for the monitoring of heparin therapy | Thrombosis Research | | | 2017 | 474 | 0 |
|
| Laboratory and Genetic Investigation of Mutations Accounting for Congenital Fibrinogen Disorders | Seminars in thrombosis and hemostasis | | | 2016 | 593 | 0 |
|
| Pregnancy | Trauma Induced Coagulopathy | | | 2016 | 446 | 2 |
|
| Diagnostic des anomalies congénitales du fibrinogène | Annales de biologie clinique | | | 2016 | 690 | 1 |
|
| Clinical Features and Management of Congenital Fibrinogen Deficiencies | Seminars in thrombosis and hemostasis | | | 2016 | 616 | 5 |
|
| Can the phenotype of inherited fibrinogen disorders be predicted? | Haemophilia | | | 2016 | 663 | 2 |
|
| Factor concentrates for rare congenital coagulation disorders: where are we now? | Expert opinion on orphan drugs | | | 2016 | 470 | 0 |
|
| Management of congenital quantitative fibrinogen disorders: a Delphi consensus | Haemophilia | | | 2016 | 545 | 0 |
|
| Risks of venous thromboembolism after cesarean sections: A meta-analysis | Chest | | | 2016 | 512 | 0 |
|
| Congenital Disorders of Fibrinogen: Clinical Presentations, Diagnosis and Management | Nonmalignant Hematology Expert Clinical Review : Questions and Answers | | | 2016 | 518 | 0 |
|
| Natural history of patients with congenital dysfibrinogenemia | Blood | | | 2015 | 750 | 4 |
|
| Successful pregnancy under fibrinogen substitution in a woman with congenital afibrinogenaemia complicated by a postpartum venous thrombosis | Haemophilia | | | 2015 | 534 | 0 |
|
| Dysfibrinogenemia: from molecular anomalies to clinical manifestations and management | Journal of thrombosis and haemostasis | | | 2015 | 809 | 748 |
|
| Maladies héréditaires du fibrinogène: de la biologie moléculaire à la clinique | | | | 2015 | 1,243 | 23 |
|
| Fibrin clot structure in patients with congenital dysfibrinogenaemia | Thrombosis research | | | 2015 | 570 | 2 |
|
| Hypofibrinogenemia and liver disease: a new case of Aguadilla fibrinogen and review of the literature | Haemophilia | | | 2015 | 606 | 5 |
|
| Comparing Two Types of Rabbit ATG prior to Reduced Intensity Conditioning Allogeneic Hematopoietic SCT for Hematologic Malignancies | Bone marrow research | | | 2015 | 727 | 405 |
|
| Hémostase. Aspirine: une ou deux fois par jour? | Revue médicale suisse | | | 2014 | 596 | 0 |
|
| Validation of the disease risk index for outcome of patients undergoing allogeneic hematopoietic stem cell transplantation after T cell depletion | Biology of blood and marrow transplantation | | | 2014 | 633 | 1 |
|
| Fibrinogen geneva II: a new congenitally abnormal fibrinogen alpha chain (Gly17Asp) with a review of similar mutations resulting in abnormal knob A | Blood coagulation & fibrinolysis | | | 2014 | 670 | 3 |
|
| FGB mutations leading to congenital quantitative fibrinogen deficiencies: an update and report of four novel mutations | Thrombosis research | | | 2014 | 711 | 9 |
|
| Acquired factor XIII deficiency: a therapeutic challenge | Thrombosis and haemostasis | | | 2013 | 657 | 0 |
|
| Hémostase : nouveaux anticoagulants oraux : de la théorie à la pratique | Revue médicale suisse | | | 2013 | 421 | 0 |
|
| Pulmonary embolism and fatal stroke in a patient with severe factor XI deficiency after bariatric surgery | Blood coagulation & fibrinolysis | | | 2013 | 526 | 0 |
|
| Could Factor XIII be a solution for the management of surgical bleeding? | Management and Severe Bleeding | | | 2013 | 391 | 0 |
|
| Congenital fibrinogen disorders: an update | Seminars in thrombosis and hemostasis | | | 2013 | 760 | 0 |
|
| Thrombotic complications of myeloproliferative neoplasms: risk assessment and risk-guided management | Journal of thrombosis and haemostasis | | | 2013 | 700 | 0 |
|
| Thrombophilie : quel bilan en 2012? | La Revue de médecine interne | | | 2012 | 515 | 0 |
|
| Recurrent Syncope due to Esophageal Squamous Cell Carcinoma | Case reports in oncology | | | 2011 | 707 | 344 |
|
